Filter by: Subject

Filter by: Subject

Results Per Page:

Multidrug-resistant tuberculosis (MDR-TB) (10)
Extensively drug-resistant tuberculosis (XDR-TB) (3)
Mycobacterium tuberculosis (MTB) (3)
Tuberculosis (TB) (3)
Bedaquiline (2)
Drug susceptibility testing (DST) (2)
Rifampicin-resistant tuberculosis (2)
South Africa (SA) (2)
Antitubercular agents (1)
Area under the curve (1)
Bedaquiline-pretonamid-linezolid (BPaL) (1)
Beta-lactams (1)
Biological marker (1)
Capreomycin (1)
CD4+ T lymphocyte (1)
Culture conversion (1)
Detection system (1)
Disease severity (1)
Drug sensitivity (1)
Drug tolerance -- Research (1)
Drug-resistance (1)
Drug-resistant tuberculosis (DR-TB) (1)
Ethambutol (EMB) (1)
Flow cytometry (1)
Fluoroquinolones (FLQ) (1)
GenoType MTBDRsl version 2.0 (1)
Hollow fiber model system (1)
Immunoassay (1)
Intramuscular injections (1)
Isoniazid (INH) (1)
Isoniazid mono-resistant tuberculosis (1)
Kanamycin (KAN) (1)
Ki 67 antigen (1)
Line probe assay (LPA) (1)
Line-probe assay (1)
Lung cavities (1)
MGIT 960 system (1)
Microbiological examination (1)
Molecular diagnostic testing (1)
Mycobacteria tuberculosis (1)
Mycobacterium tuberculosis (1)
Obesity (1)
Ofloxacin (OFL) (1)
Pharmacodynamics (1)
Pharmacokinetics (1)
Polymerase chain reaction (PCR) (1)
Quality control (QC) (1)
Receiver operating characteristic (1)
Regulatory T lymphocyte (1)
Rifampicin (RIF) (1)
SDG-03: Good health and well-being (1)
Second-line injectable drugs (SLID) (1)
Sensitivity (1)
Smear grades (1)
South Africa (1)
Specificity (1)
Sputum culture (1)
Time to culture conversion (TCC) (1)
Transmission (1)
Treg cells (1)
Tuberculosis -- Complications -- South Africa (1)
Tuberculosis drug resistance (1)
Underweight (1)
β-lactamase inhibitors (BLIs) (1)